Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
egQSaFftkv2JnmaS
